| Members |
targetComponentId |
| vareniklin 0,5 mg, tablett |
Varenicline (as varenicline tartrate) 500 microgram oral tablet |
| velagluceras alfa 400 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| venlafaxin 37,5 mg, tablett |
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
| venlafaxin 50 mg, tablett |
Venlafaxine (as venlafaxine hydrochloride) 50 mg oral tablet |
| venlafaxin 75 mg, tablett |
Venlafaxine (as venlafaxine hydrochloride) 75 mg oral tablet |
| vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| vinorelbin (som vinorelbintartrat) 50 mg/5 ml, infusionsvätska, lösning, flaska |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| xylometazolinhydroklorid 500 mikrogram/milliliter, näsdroppar, lösning |
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release nasal drops (clinical drug) |
| zinksulfatmonohydrat 125 milligram, brustablett |
Product containing precisely zinc (as zinc sulfate) 45 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| zuklopentixol 10 mg, tablett |
Zuclopenthixol (as zuclopenthixol dihydrochloride) 10 mg oral tablet |
| zuklopentixol 2 mg, tablett |
Zuclopenthixol (as zuclopenthixol dihydrochloride) 2 mg oral tablet |
| zuklopentixol 25 mg, tablett |
Product containing precisely zuclopenthixol (as zuclopenthixol dihydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) |
| läkemedel som innehåller natriumklorid, för orofaryngealt bruk |
Product containing sodium chloride in oromucosal dose form (medicinal product form) |
| läkemedel som innehåller natriumkondroitinsulfat |
Chondroitin-containing product |
| natriumdiatrizoat |
Product containing amidotrizoic acid (medicinal product) |
| natriumamidotrizoat för parenteralt bruk |
Amidotrizoic acid-containing product in parenteral dose form |
| läkemedel som innehåller natriumfluorid, för orofaryngealt bruk |
Product containing sodium fluoride in oromucosal dose form (medicinal product form) |
| natriumoxibat |
Product containing 4-hydroxybutyric acid (medicinal product) |
| natriumaminohippurat |
Para-aminohippuric acid-containing product |
| läkemedel som innehåller natriumperborat, för orofaryngealt bruk |
Sodium perborate-containing product in oromucosal dose form |
| natriumfenylbutyrat för oralt bruk |
Phenylbutyric acid only product in oral dose form |
| läkemedel som innehåller sufentanil, sublingual läkemedelsform |
Sufentanil-containing product in oromucosal dose form |
| läkemedel som innehåller testosteron, för orofaryngealt bruk |
Product containing testosterone in oromucosal dose form (medicinal product form) |
| läkemedel som innehåller testosteron, subkutan läkemedelsform |
Testosterone-containing product in parenteral dose form |
| läkemedel som innehåller tetrakain, för orofaryngealt bruk |
Product containing tetracaine in oromucosal dose form (medicinal product form) |
| läkemedel som innehåller triamcinolon, för orofaryngealt bruk |
Triamcinolone-containing product in oromucosal dose form |
| läkemedel som innehåller tricyklisk förening |
Medicinal product containing tricyclic compound and acting as antidepressant agent (product) |
| zinkundecenoat + undecylensyra |
Product containing undecylenic acid (medicinal product) |
| läkemedel som innehåller uratoxidas |
Product containing enzyme (product) |
| läkemedel som innehåller uratoxidas, parenteral läkemedelsform |
Product containing enzyme (product) |
| läkemedel, för orofaryngealt bruk |
Product manufactured as oromucosal dose form (product) |
| progesteron 100 mg, vagitorium |
Progesterone 100 mg vaginal tablet |
| progesteron 200 mg, suppositorium eller vagitorium |
Progesterone only product |
| progesteron 400 mg, suppositorium eller vagitorium |
Progesterone only product |
| progesteron 50 mg/ml, olja |
Progesterone 50 mg/mL solution for injection |
| filmdragerad kapsel med förlängd frisättning |
Prolonged-release oral capsule |
| Prolymphocytic leukemia |
Prolymphocytic leukaemia |
| promazin 12,5 mg/5 ml, sirap |
Promazine 2.5 mg/mL oral solution |
| promazinhydroklorid 50 mg/5 ml, oral sirap |
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| promazinhydroklorid 50 mg/5 ml, sockerfri sirap |
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Promegakaryocyte |
Promegakaryocyte |
| prometazin 6,25 mg/5 ml + dextrometorfan 15 mg/5 ml, oral sirap |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
| prometazinhydroklorid 25 mg/5 ml, sirap |
Product containing precisely promethazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Promethazine hydrochloride 50mg injection |
Product containing precisely promethazine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| prometazinhydroklorid 50 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely promethazine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| prometazinhydroklorid 6,25 mg/5 ml, sirap |
Product containing precisely promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| propafenonhydroklorid, 225 mg kapsel med modifierad frisättning |
Propafenone only product in oral dose form |
| propafenonhydroklorid 225 mg, depåkapsel |
Propafenone only product in oral dose form |
| propafenonhydroklorid, 325 mg kapsel med modifierad frisättning |
Propafenone only product in oral dose form |
| propafenonhydroklorid 325 mg, depåkapsel |
Propafenone only product in oral dose form |
| propafenonhydroklorid, 425 mg kapsel med modifierad frisättning |
Propafenone only product in oral dose form |
| propafenonhydroklorid 425 mg, depåkapsel |
Propafenone only product in oral dose form |
| Propamidine isethionate |
Product containing propamidine (medicinal product) |
| dibrompropamidinisetionat 0,1 %, ögondroppar |
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
| propamidinisetionatallergi |
Allergy to propamidine (finding) |
| Proparacaine hydrochloride 0.5% solution |
Proparacaine hydrochloride 5 mg/mL eye solution |
| Proparacaine hydrochloride 0.5%vv solution |
Proparacaine hydrochloride 5 mg/mL eye solution |
| typ av egenskap |
Property (attribute) |
| Propess 10mg pessary |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Propiomazine |
Product containing propiomazine (medicinal product) |
| Propioniferax innocus |
Propioniferax innocua (organism) |
| Propiverine hydrochloride |
Product containing propiverine (medicinal product) |
| propofol 10 mg/ml, injektionsvätska, emulsion |
Propofol 10 mg/mL emulsion for injection |
| propofol 20 mg/ml, injektionsvätska, emulsion |
Product containing only propofol in parenteral dose form (medicinal product form) |
| Propranolol hydrochloride |
Product containing propranolol (medicinal product) |
| Propranolol hydrochloride + bendrofluazide |
Product containing bendroflumethiazide and propranolol (medicinal product) |
| propranololhydroklorid 10 mg/5 ml, sirap |
Product containing precisely propranolol hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
| propranololhydroklorid 120 mg, kapsel med modifierad frisättning |
Product containing only propranolol in oral dose form (medicinal product form) |
| propranololhydroklorid 120 mg, depåkapsel |
Product containing only propranolol in oral dose form (medicinal product form) |
| propranololhydroklorid 40 mg/5 ml, sirap |
Propranolol hydrochloride 8 mg/mL oral solution |
| propranololhydroklorid 50 mg/5 ml, sirap |
Propranolol hydrochloride 10 mg/mL oral solution |
| propranololhydroklorid 5 mg/5 ml, sirap |
Propranolol hydrochloride 1 mg/mL oral solution |
| propranololhydroklorid 60 mg, kapsel med modifierad frisättning |
Product containing only propranolol in oral dose form (medicinal product form) |
| propranololhydroklorid 60 mg, depåkapsel |
Product containing only propranolol in oral dose form (medicinal product form) |
| propranololhydroklorid 80 mg/5 ml, sirap |
Propranolol hydrochloride 16 mg/mL oral solution |
| Propranolol hydrochloride [2] |
Product containing propranolol (medicinal product) |
| Prostaglandin PGA |
A series prostaglandin (substance) |
| Prostaglandin PGD |
D series prostaglandin (substance) |
| Prostaglandin PGE |
E series prostaglandin (substance) |
| Prostaglandin PGF |
F series prostaglandin (substance) |
| Prostate excision |
Prostatectomy |
| Prostatic lithiasis |
Calculus of prostate |
| protesstatus |
Prosthetic device status (observable entity) |
| Prosthetic implant |
Prosthetic implant |
| Prosthetic ligament reconstruction |
Repair - action |
| Prosthetic ligament supporting tissue ingrowth reconstruction |
Repair - action |
| Prosthetic replacement |
Insertion - action (qualifier value) |
| ersättning av fyra eller fler koronarartärer med protes |
Bypass of four or more coronary arteries with prosthesis (procedure) |
| ersättning av en koronarartär med protes |
Bypass of one coronary artery with prosthesis (procedure) |
| ersättning av tre koronarartärer med protes |
Bypass of three coronary arteries with prosthesis (procedure) |
| ersättning av två koronarartärer med protes |
Bypass of two coronary arteries with prosthesis (procedure) |
| protaminextrakt |
Product containing protamine (medicinal product) |
| Protective products |
Glove |
| Protein C activation peptide |
Protein S |
| protein och proteinderivat, livsmedel |
Protein and/or protein derivative |
| Proteus vulgaris biogroup 3 |
Proteus hauseri (organism) |
| Protirelin 500mcg/mL injection |
Product containing only protirelin in parenteral dose form (medicinal product form) |
| protirelin 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Product containing only protirelin in parenteral dose form (medicinal product form) |
| Protirelin preparation |
Product containing thyrotropin releasing factor (medicinal product) |
| Proton |
Proton |
| Providencia friedericiana |
Providencia rustigianii |
FHIR